Q2 2018 Holdings
Filed 2018-08-13 | 18 holdings | $76.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $33.5M | 504,210 | 43.6% |
| Argenx(ARGX) | COM | 04016X101 | $29.0M | 346,792 | 37.7% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $14.1M | 2,464,241 | 18.4% |
| Endocyte Inc | COM | 29269A102 | $59.3K | 4,300,000 | 0.1% |
| Biohaven Pharmaceuticals(BHVN) | COM | G11196105 | $55.9K | 1,415,391 | 0.1% |
| Obseva SA | COM | H5861P103 | $34.1K | 2,252,460 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $28.8K | 962,696 | 0.0% |
| Zogenix | COM | 98978L204 | $16.0K | 362,010 | 0.0% |
| DBV Technologies | COM | 23306J101 | $12.0K | 463,149 | 0.0% |
| Kiniksa Pharmaceuticals Ltd | COM | G5269C101 | $11.1K | 639,230 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $10.0K | 4,149,378 | 0.0% |
| Momenta Pharmaceuticals(MNTA) | COM | 60877T100 | $8.7K | 425,000 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $7.0K | 474,015 | 0.0% |
| Kadmon Holdings Inc.(KDMN) | COM | 48283N106 | $5.6K | 1,411,428 | 0.0% |
| Ra Pharmaceuticals | COM | 74933V108 | $5.4K | 544,612 | 0.0% |
| Marinus Pharmaceuticals Inc | COM | 56854Q101 | $2.4K | 345,240 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $654 | 29,710 | 0.0% |
| ChemoCentryx Inc(CCXIEUR) | COM | 16383L106 | $304 | 23,064 | 0.0% |